Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus)

Prediabetes, also commonly referred to as borderline diabetes, is a metabolic condition and growing global problem that is closely tied to obesity. Prediabetes is the precursor stage before diabetes mellitus in which not all of the symptoms required to diagnose diabetes are present, but blood sugar is abnormally high. Prediabetes is characterized by the presence of blood glucose levels that are higher than normal but not yet high enough to be classed as diabetes.
For this reason, prediabetes is often described as the “gray area” between normal blood sugar and diabetic levels. In the UK, around 7 million people are estimated to have prediabetes and thus have a high risk for developing type 2 diabetes. Prediabetes is associated with obesity (especially abdominal or visceral obesity), dyslipidemia with high triglycerides and/or low HDL cholesterol, and hypertension. It is thus a metabolic diathesis or syndrome, and it usually involves no symptoms and only high blood sugar as the sole sign.
The progression to type 2 diabetes mellitus is not inevitable for those with prediabetes. The progression into diabetes mellitus from prediabetes is approximately 25% over three to five years. For patients with severe risk factors, prescription medication may be appropriate. This may be considered in patients for whom lifestyle therapy has failed, or is not sustainable, and who are at high-risk for developing type 2 diabetes. Metformin and acarbose help prevent the development of frank diabetes, and also have a good safety profile. The most serious consequence of prediabetes is progression to type 2 diabetes.
 

  • Impaired fasting glycaemia
  • Impaired glucose tolerance
  • Insulin resistance
  • Tests for Pre-Diabetes
  • Cardiovascular diseases
  • Genetic Influence on Pre-diabetes
  • Healthy Meals and Physical Exercise
  • Type 2 Diabetes
  • GFR Estimation To Stop Kidney Disease
  • Erectile dysfunction and Nocturia

Related Conference of Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus)

June 05-06, 2023

World Congress on Endocrine and Diabetes

San Francisco, USA
June 15-16, 2023

4thAnnual conference on Diabetes

San Francisco, USA
July 24-25, 2023

18th International Summit on Diabetes

Venice, Italy
July 24-25, 2023

56th Annual Congress on Endocrinology & Disorders

Venice, Italy
August 10-11, 2023

25th World Congress on Diabetes and Endocrine Disorders

Dublin, Ireland
September 07-08, 2023

19th World Congress on Endocrinology & Diabetes

Amsterdam, Netherlands
September 12-13, 2023

7th Annual Conference on Diabetes and Endocrinology

Barcelona, Spain
September 14-15, 2023

3rd Annual Summit on Diabetes and Endocrinology

Bangkok, Thailand
October 16-17, 2023

4th Asia Pacific Congress on Diabetes and Endocrinology

Vancouver, Canada
October 16-17, 2023

2nd World congress and Expo on Diabetes

Vancouver, Canada
October 21-22, 2023

4th World Summit on Diabetes Expo

New York, USA
November 16-17, 2023

3rd European Endocrinology and Diabetes Congress

Paris, France
November 20-21, 2023

17th European Diabetes and Endocrinology Congress

Dubai, UAE
November 27-28, 2023

27th International Conference on Diabetes, Endocrinology and Healthcare

Singapore City, Singapore
December 06-07, 2023

21th World Congress on Endocrine Neoplasia & Cancer

Dubai, UAE

Pre-Diabetes/Borderline Diabetes (Pre-cursor to Diabetes Mellitus) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in